Baseline characteristics of the population sample according to the AP and or OAC treatment
| . | Group 1 (n= 220) . | Group 2 (n= 60) . | Group 3 (n= 40) . | Group 4 (n= 375) . | Group 5 (n= 154) . |
|---|---|---|---|---|---|
| Age (years) | 74 ± 11 | 72 ± 8 | 70 ± 8 | 69 ± 18 | 70 ± 15 |
| Male (n, %) | 150 (68%) | 49 (83%) | 31 (78%) | 206 (55%) | 88 (57%) |
| Hypertension (n, %) | 151 (72%) | 43 (74%) | 33 (83%) | 179 (51%) | 98 (64%) |
| Diabetes (n, %) | 86 (41%) | 24 (41%) | 16 (40%) | 71 (20%) | 39 (26%) |
| Dyslipidaemia (n, %) | 101 (48%) | 35 (60%) | 29 (73%) | 75 (21%) | 57 (37%) |
| Obesity (n, %)a | 68 (34%) | 18 (32%) | 19 (50%) | 116 (34%) | 52 (36%) |
| Atrial fibrillation (n, %)b | 45 (21%) | 12 (20%) | 26 (65%) | 50 (14%) | 123 (81%) |
| Ischaemic heart disease (n, %) | 86 (40%) | 50 (83%) | 26 (65%) | 27 (7.4%) | 23 (15%) |
| Previous Stroke | 25 (12%) | 5 (8.3%) | 5 (13%) | 7 (2%) | 13 (9%) |
| Renal insufficiency (n, %)c | 21 (10%) | 6 (10%) | 9 (23%) | 23 (6.5%) | 14 (9%) |
| Device | |||||
| Pacemaker | 149 (68%) | 23 (38%) | 14 (35%) | 289 (77%) | 111 (72%) |
| ICD | 40 (18%) | 21 (36%) | 15 (38%) | 55 (15%) | 14 (9%) |
| CRT + ICD | 31 (14%) | 15 (25%) | 11 (27%) | 31 (8%) | 29 (19%) |
| Procedure | |||||
| New implant | 164 (75%) | 49 (82%) | 31 (78%) | 260 (69%) | 105 (68%) |
| Generator replacement | 50 (23%) | 9 (15%) | 5 (12%) | 105 (28%) | 37 (24%) |
| Upgrading | 6 (2%) | 2 (3%) | 4 (10%) | 10 (3%) | 12 (8%) |
| Platelet count (×109/L) (mean ± SD) | 205 ± 60 | 216 ± 77 | 207 ± 75 | 204 ± 80 | 205 ± 70 |
| INR (mean ± SD) | 1.07 ± 0.11 | 1.10 ± 0.13 | 1.11 ± 0.43 | 1.08 ± 0.11 | 1.09 ± 0.25 |
| . | Group 1 (n= 220) . | Group 2 (n= 60) . | Group 3 (n= 40) . | Group 4 (n= 375) . | Group 5 (n= 154) . |
|---|---|---|---|---|---|
| Age (years) | 74 ± 11 | 72 ± 8 | 70 ± 8 | 69 ± 18 | 70 ± 15 |
| Male (n, %) | 150 (68%) | 49 (83%) | 31 (78%) | 206 (55%) | 88 (57%) |
| Hypertension (n, %) | 151 (72%) | 43 (74%) | 33 (83%) | 179 (51%) | 98 (64%) |
| Diabetes (n, %) | 86 (41%) | 24 (41%) | 16 (40%) | 71 (20%) | 39 (26%) |
| Dyslipidaemia (n, %) | 101 (48%) | 35 (60%) | 29 (73%) | 75 (21%) | 57 (37%) |
| Obesity (n, %)a | 68 (34%) | 18 (32%) | 19 (50%) | 116 (34%) | 52 (36%) |
| Atrial fibrillation (n, %)b | 45 (21%) | 12 (20%) | 26 (65%) | 50 (14%) | 123 (81%) |
| Ischaemic heart disease (n, %) | 86 (40%) | 50 (83%) | 26 (65%) | 27 (7.4%) | 23 (15%) |
| Previous Stroke | 25 (12%) | 5 (8.3%) | 5 (13%) | 7 (2%) | 13 (9%) |
| Renal insufficiency (n, %)c | 21 (10%) | 6 (10%) | 9 (23%) | 23 (6.5%) | 14 (9%) |
| Device | |||||
| Pacemaker | 149 (68%) | 23 (38%) | 14 (35%) | 289 (77%) | 111 (72%) |
| ICD | 40 (18%) | 21 (36%) | 15 (38%) | 55 (15%) | 14 (9%) |
| CRT + ICD | 31 (14%) | 15 (25%) | 11 (27%) | 31 (8%) | 29 (19%) |
| Procedure | |||||
| New implant | 164 (75%) | 49 (82%) | 31 (78%) | 260 (69%) | 105 (68%) |
| Generator replacement | 50 (23%) | 9 (15%) | 5 (12%) | 105 (28%) | 37 (24%) |
| Upgrading | 6 (2%) | 2 (3%) | 4 (10%) | 10 (3%) | 12 (8%) |
| Platelet count (×109/L) (mean ± SD) | 205 ± 60 | 216 ± 77 | 207 ± 75 | 204 ± 80 | 205 ± 70 |
| INR (mean ± SD) | 1.07 ± 0.11 | 1.10 ± 0.13 | 1.11 ± 0.43 | 1.08 ± 0.11 | 1.09 ± 0.25 |
aObesity is defined as a Body Mass Index ≥30.
bAny previous episode of atrial fibrillation.
cRenal insufficiency is defined as a glomerular filtration rate < 60 mL/min/1.73 m2.
Baseline characteristics of the population sample according to the AP and or OAC treatment
| . | Group 1 (n= 220) . | Group 2 (n= 60) . | Group 3 (n= 40) . | Group 4 (n= 375) . | Group 5 (n= 154) . |
|---|---|---|---|---|---|
| Age (years) | 74 ± 11 | 72 ± 8 | 70 ± 8 | 69 ± 18 | 70 ± 15 |
| Male (n, %) | 150 (68%) | 49 (83%) | 31 (78%) | 206 (55%) | 88 (57%) |
| Hypertension (n, %) | 151 (72%) | 43 (74%) | 33 (83%) | 179 (51%) | 98 (64%) |
| Diabetes (n, %) | 86 (41%) | 24 (41%) | 16 (40%) | 71 (20%) | 39 (26%) |
| Dyslipidaemia (n, %) | 101 (48%) | 35 (60%) | 29 (73%) | 75 (21%) | 57 (37%) |
| Obesity (n, %)a | 68 (34%) | 18 (32%) | 19 (50%) | 116 (34%) | 52 (36%) |
| Atrial fibrillation (n, %)b | 45 (21%) | 12 (20%) | 26 (65%) | 50 (14%) | 123 (81%) |
| Ischaemic heart disease (n, %) | 86 (40%) | 50 (83%) | 26 (65%) | 27 (7.4%) | 23 (15%) |
| Previous Stroke | 25 (12%) | 5 (8.3%) | 5 (13%) | 7 (2%) | 13 (9%) |
| Renal insufficiency (n, %)c | 21 (10%) | 6 (10%) | 9 (23%) | 23 (6.5%) | 14 (9%) |
| Device | |||||
| Pacemaker | 149 (68%) | 23 (38%) | 14 (35%) | 289 (77%) | 111 (72%) |
| ICD | 40 (18%) | 21 (36%) | 15 (38%) | 55 (15%) | 14 (9%) |
| CRT + ICD | 31 (14%) | 15 (25%) | 11 (27%) | 31 (8%) | 29 (19%) |
| Procedure | |||||
| New implant | 164 (75%) | 49 (82%) | 31 (78%) | 260 (69%) | 105 (68%) |
| Generator replacement | 50 (23%) | 9 (15%) | 5 (12%) | 105 (28%) | 37 (24%) |
| Upgrading | 6 (2%) | 2 (3%) | 4 (10%) | 10 (3%) | 12 (8%) |
| Platelet count (×109/L) (mean ± SD) | 205 ± 60 | 216 ± 77 | 207 ± 75 | 204 ± 80 | 205 ± 70 |
| INR (mean ± SD) | 1.07 ± 0.11 | 1.10 ± 0.13 | 1.11 ± 0.43 | 1.08 ± 0.11 | 1.09 ± 0.25 |
| . | Group 1 (n= 220) . | Group 2 (n= 60) . | Group 3 (n= 40) . | Group 4 (n= 375) . | Group 5 (n= 154) . |
|---|---|---|---|---|---|
| Age (years) | 74 ± 11 | 72 ± 8 | 70 ± 8 | 69 ± 18 | 70 ± 15 |
| Male (n, %) | 150 (68%) | 49 (83%) | 31 (78%) | 206 (55%) | 88 (57%) |
| Hypertension (n, %) | 151 (72%) | 43 (74%) | 33 (83%) | 179 (51%) | 98 (64%) |
| Diabetes (n, %) | 86 (41%) | 24 (41%) | 16 (40%) | 71 (20%) | 39 (26%) |
| Dyslipidaemia (n, %) | 101 (48%) | 35 (60%) | 29 (73%) | 75 (21%) | 57 (37%) |
| Obesity (n, %)a | 68 (34%) | 18 (32%) | 19 (50%) | 116 (34%) | 52 (36%) |
| Atrial fibrillation (n, %)b | 45 (21%) | 12 (20%) | 26 (65%) | 50 (14%) | 123 (81%) |
| Ischaemic heart disease (n, %) | 86 (40%) | 50 (83%) | 26 (65%) | 27 (7.4%) | 23 (15%) |
| Previous Stroke | 25 (12%) | 5 (8.3%) | 5 (13%) | 7 (2%) | 13 (9%) |
| Renal insufficiency (n, %)c | 21 (10%) | 6 (10%) | 9 (23%) | 23 (6.5%) | 14 (9%) |
| Device | |||||
| Pacemaker | 149 (68%) | 23 (38%) | 14 (35%) | 289 (77%) | 111 (72%) |
| ICD | 40 (18%) | 21 (36%) | 15 (38%) | 55 (15%) | 14 (9%) |
| CRT + ICD | 31 (14%) | 15 (25%) | 11 (27%) | 31 (8%) | 29 (19%) |
| Procedure | |||||
| New implant | 164 (75%) | 49 (82%) | 31 (78%) | 260 (69%) | 105 (68%) |
| Generator replacement | 50 (23%) | 9 (15%) | 5 (12%) | 105 (28%) | 37 (24%) |
| Upgrading | 6 (2%) | 2 (3%) | 4 (10%) | 10 (3%) | 12 (8%) |
| Platelet count (×109/L) (mean ± SD) | 205 ± 60 | 216 ± 77 | 207 ± 75 | 204 ± 80 | 205 ± 70 |
| INR (mean ± SD) | 1.07 ± 0.11 | 1.10 ± 0.13 | 1.11 ± 0.43 | 1.08 ± 0.11 | 1.09 ± 0.25 |
aObesity is defined as a Body Mass Index ≥30.
bAny previous episode of atrial fibrillation.
cRenal insufficiency is defined as a glomerular filtration rate < 60 mL/min/1.73 m2.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
